PLV for
Business A = (15+15)x0.28 -15 = - 6.6
Business B = ( 11+144)x0.28 -10 = 33.4
Business C = ( 4+139)x0.1 -12 = 2.3
Business D = (100+24)x0.2 -8 = 16.8
Considering Above values, the business A has negative value of PLV so it should not be acquired. among rest of the three businesses. B and D have healthy PLVs so they can be acquired, while C can also be pursued having positive PLV .
The answer is No, because each one of the four can't be acquired.
Analytics Mini Case: Evaluating the Prospect Lifetime Value of new Customers in a B2B Setting You...
You are part of an accounting firm Advisory team that has been engaged by a client to assess how they might make their “sales to order” process more “efficient”, perhaps with the introduction of new technologies. The client has provided a written description of their business, and the process under review, as follows: HHH is a small manufacturer of university based sportswear (a highly competitive market where fast response times are prized by customers). Sales span every region of the...
You are part of an accounting firm Advisory team that has been engaged by a client to assess how they might make their “sales to order” process more “efficient”, perhaps with the introduction of new technologies. The client has provided a written description of their business, and the process under review, as follows: HHH is a small manufacturer of university based sportswear (a highly competitive market where fast response times are prized by customers). Sales span every region of the...
Please read the article bellow and discuss the shift in the company's approach to genetic analysis. Please also discuss what you think about personal genomic companies' approaches to research. Feel free to compare 23andMe's polices on research with another company's. Did you think the FDA was right in prohibiting 23andMe from providing health information? These are some sample talking points to get you thinking about the ethics of genetic research in the context of Big Data. You don't have to...